EMP3 and central nervous system cancer: Analysis of glioma patients collected in the CGGA database showed that the overall survival of patients with high EMP3 expression was significantly shorter than that of patients with low EMP3 expression (P < 0.001, HR:4.63, Fig. 3A), and the same results were obtained in the TCGA database (P < 0.001, HR:7.36, Fig. 3B).